Oncofetal TRIM71 drives liver cancer carcinogenesis through remodeling CEBPA-mediated serine/glycine metabolism

作者：Ying Su, Ziteng Li, Qin Li, Xinyi Guo, Hena Zhang, Zhiyong Li, Zhiqiang Meng, Shenglin Huang, Zhixiang Hu · 发表于：Theranostics · 年份：2024 · DOI：10.7150/thno.99633 · 被引用次数：20 · 研究领域：RNA modifications and cancer、interferon and immune responses、Biochemical and Molecular Research

We demonstrated the oncofetal status in liver cancer and highlighted the crucial role of TRIM71 and provided potential therapeutic strategies and liver cancer-specific biomarker for liver cancer patients.